Prostate Cancer
Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management - Beyond the Abstract
October 17, 2024
Survival of Men with Metastatic Hormone-Sensitive Prostate Cancer and Adrenal-Permissive HSD3B1 Inheritance - Beyond the Abstract
October 15, 2024
Hospital-Level Variability in the Adoption of Image-Guided Focal Therapy for Localized Prostate and Kidney Cancer - Beyond the Abstract
October 3, 2024
Prospective Comparison of 68Ga-NeoB and 68Ga-PSMA-R2 PET/MRI in Patients with Biochemically Recurrent Prostate Cancer - Beyond the Abstract
September 26, 2024
Identifying Barriers to Timely Follow-up After Elevated PSA Screening: A Retrospective Analysis of a Large Healthcare System - Beyond the Abstract
September 25, 2024
Cost-Utility Analysis of Navigate, a Treatment Decision Aid for Men with Prostate Cancer and Their Partners, in Comparison to Usual Care - Beyond the Abstract
September 25, 2024
Neurologic Symptoms after 177Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience - Beyond the Abstract
September 25, 2024
5-α Reductase Inhibitors and Prostate Cancer Mortality - Beyond the Abstract
September 20, 2024
Long Noncoding RNA EPCART Regulates Translation Through PI3K/AKT/mTOR Pathway and PDCD4 in Prostate Cancer - Beyond the Abstract
September 9, 2024